The global market for Critical Care Diagnostics was estimated at US$1.4 Billion in 2023, and is projected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Immunoproteins segment, which is expected to reach US$713.5 Million by 2030 with a CAGR of a 4.8%. The Routine & Special Chemistry segment is also set to grow at 8.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $354.7 Million in 2023, and China, forecasted to grow at an impressive 9.0% CAGR to reach $466.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Critical Care Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Critical Care Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Critical Care Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 103 Featured):
- Abbott Laboratories
- Alere, Inc.
- Bayer Healthcare AG
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- BioMerieux, Inc.
- Bio-Rad Laboratories, Inc.
- Biosensors Japan Co., Ltd.
- Chembio Diagnostic Systems, Inc.
- EKF Diagnostics Holdings PLC
- Nanomix, Inc.
- Nova Biomedical Corporation
- Roche Diagnostics (Schweiz) AG
- Siemens Healthineers
- Sysmex Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- Critical Care Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
3. MARKET TRENDS & DRIVERS
- Rising Global Incidence of Chronic Conditions Drives Demand for Critical Care Diagnostics
- Technological Advancements in Point-of-Care Diagnostics Enhance Critical Care
- Growing Need for Rapid Diagnostic Techniques in Emergency Rooms
- Integration of Telemedicine and Remote Monitoring in Critical Care Settings
- Expansion of Healthcare Infrastructure Globally Bolsters Diagnostics Market
- Aging Population and Increased Susceptibility to Acute Conditions Propel Market Growth
- Demand for Non-invasive Diagnostic Solutions in Critical Care
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Critical Care Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Immunoproteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Immunoproteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Immunoproteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Coagulation Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for Coagulation Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for Coagulation Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 19: World Critical Care Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- Table 20: World Recent Past, Current & Future Analysis for Routine & Special Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 21: World Historic Review for Routine & Special Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 22: World 16-Year Perspective for Routine & Special Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 23: World Recent Past, Current & Future Analysis for Microbial & Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 24: World Historic Review for Microbial & Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 25: World 16-Year Perspective for Microbial & Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
UNITED STATES
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: USA Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: USA 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: Canada Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: Canada 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
JAPAN
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 32: Japan Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Japan Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Japan 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
CHINA
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 35: China Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: China Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: China 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
EUROPE
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 38: Europe Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 39: Europe Historic Review for Critical Care Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: Europe 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 41: Europe Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: Europe Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: Europe 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
FRANCE
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 44: France Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: France Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: France 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
GERMANY
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 47: Germany Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 48: Germany Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: Germany 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
ITALY
- Table 50: Italy Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 51: Italy Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Italy 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 53: UK Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: UK Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: UK 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
SPAIN
- Table 56: Spain Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: Spain Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: Spain 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
RUSSIA
- Table 59: Russia Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: Russia Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: Russia 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 62: Rest of Europe Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: Rest of Europe Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: Rest of Europe 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 66: Asia-Pacific Historic Review for Critical Care Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Asia-Pacific 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Asia-Pacific Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Asia-Pacific 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
AUSTRALIA
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
LATIN AMERICA
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned
- Abbott Laboratories
- Alere, Inc.
- Bayer Healthcare AG
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- BioMerieux, Inc.
- Bio-Rad Laboratories, Inc.
- Biosensors Japan Co., Ltd.
- Chembio Diagnostic Systems, Inc.
- EKF Diagnostics Holdings PLC
- Nanomix, Inc.
- Nova Biomedical Corporation
- Roche Diagnostics (Schweiz) AG
- Siemens Healthineers
- Sysmex Corporation
